Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy

被引：0
|
作者：
Zachary D Horne
David A Clump
John A Vargo
Samir Shah
Sushil Beriwal
Steven A Burton
Annette E Quinn
Matthew J Schuchert
Rodney J Landreneau
Neil A Christie
James D Luketich
Dwight E Heron
机构：
[1] University of Pittsburgh Cancer Institute,Department of Radiation Oncology
[2] University of Pittsburgh Medical Center,Division of Thorcic and Foregut Surgery, Department of Cardiothoracic Surgery
来源：
Radiation Oncology | / 9卷
关键词：
Overall Survival; Planning Target Volume; Stereotactic Body Radiation Therapy; Gross Tumor Volume; SUVmax Cutoff;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Anemia is a Prognostic Factor for Overall Survival Rate in Patients with Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy
    Tanaka, Hidekazu
    Ono, Taiki
    Manabe, Yuki
    Kajima, Miki
    Fujimoto, Koya
    Yuasa, Yuki
    Shiinoki, Takehiro
    Yamaji, Yoshikazu
    Matsunaga, Kazuto
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 7447 - 7453
  • [32] Outcomes of invasive mediastinal nodal staging versus positron emission tomography staging alone for early-stage non-small cell lung cancer treated with stereotactic body radiation therapy
    Schonewolf, Caitlin A.
    Verma, Vivek
    Post, Carl M.
    Berman, Abigail T.
    Frick, Melissa A.
    Vachani, Anil
    Lin, Chi
    Simone, Charles B., II
    LUNG CANCER, 2018, 117 : 53 - 59
  • [33] Prognostic index score predicts outcome of patients with Stage I non-small cell lung cancer after stereotactic body radiation therapy
    Shi, Shiming
    Ye, Luxi
    Zhao, Qianqian
    Hu, Yong
    Huang, Yan
    Chen, Gang
    Zeng, Zhaochong
    He, Jian
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (04) : 367 - 372
  • [34] Nomogram Predicting Overall Survival Benefit of Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer
    Jacobs, Corbin D.
    Mehta, Kurren
    Gao, Junheng
    Wang, Xiaofei
    Salama, Joseph K.
    Kelsey, Chris R.
    Torok, Jordan A.
    CLINICAL LUNG CANCER, 2022, 23 (02) : 177 - 184
  • [35] Unsupervised machine learning of radiomic features for predicting treatment response and overall survival of early stage non-small cell lung cancer patients treated with stereotactic body radiation therapy
    Li, Hongming
    Galperin-Aizenberg, Maya
    Pryma, Daniel
    Simone, Charles B., II
    Fan, Yong
    RADIOTHERAPY AND ONCOLOGY, 2018, 129 (02) : 218 - 226
  • [36] Lung stereotactic body radiation therapy for elderly patients aged ≥ 80 years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort study
    Kenta Watanabe
    Kuniaki Katsui
    Soichiro Sugiyama
    Kotaro Yoshio
    Masahiro Kuroda
    Takao Hiraki
    Katsuyuki Kiura
    Yoshinobu Maeda
    Shinichi Toyooka
    Susumu Kanazawa
    Radiation Oncology, 16
  • [37] Lung stereotactic body radiation therapy for elderly patients aged ≥ 80 years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort study
    Watanabe, Kenta
    Katsui, Kuniaki
    Sugiyama, Soichiro
    Yoshio, Kotaro
    Kuroda, Masahiro
    Hiraki, Takao
    Kiura, Katsuyuki
    Maeda, Yoshinobu
    Toyooka, Shinichi
    Kanazawa, Susumu
    RADIATION ONCOLOGY, 2021, 16 (01)
  • [38] Surgery Versus Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: A Comprehensive Review
    Tandberg, Daniel J.
    Tong, Betty C.
    Ackerson, Bradley G.
    Kelsey, Chris R.
    CANCER, 2018, 124 (04) : 667 - 678
  • [39] Predictors of Distant Recurrence Following Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer
    Wong, Jessica Karen
    Shaikh, Talha
    DeMora, Lyudmila
    Zhang, Eddie
    Borghaei, Hossein
    Hayes, Shelly B.
    Kumar, Sameera
    Meyer, Joshua E.
    Hallman, Mark A.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (04): : 243 - 248
  • [40] Stereotactic Body Radiation Therapy (SBRT) for Recurrent Non-small Cell Lung Cancer (NSCLC)
    Janssen, Stefan
    Kaesmann, Lukas
    Rudat, Volker
    Rades, Dirk
    ANTICANCER RESEARCH, 2016, 36 (02) : 825 - 828
12345